Nymox Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
March 30, 2021 at 02:12 am IST
Nymox Pharmaceutical Corporation announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was USD 5,000 compared to USD 116,000 a year ago. Operating loss was USD 11.720 million compared to USD 13.325 million a year ago. Net loss was USD 11.738 million compared to USD 13.162 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 0.19 a year ago.